SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-18-020997
Filing Date
2018-03-20
Accepted
2018-03-20 19:37:56
Documents
2
Period of Report
2018-03-12

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1590
2 EX-24 DOCUMENT attachment1.htm EX-24 3265
  Complete submission text file 0001209191-18-020997.txt   6240
Mailing Address 270 EAST GRAND AVENUE, SUITE 22 SOUTH SAN FRANCISCO CA 94080
Business Address 270 EAST GRAND AVENUE, SUITE 22 SOUTH SAN FRANCISCO CA 94080 650-244-6864
PORTOLA PHARMACEUTICALS INC (Issuer) CIK: 0001269021 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address ALEXION PHARMACEUTICALS 352 KNOTTER DRIVE CHESHIRE CT 06410
Business Address
Moriarty John B (Reporting) CIK: 0001564621 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35935 | Film No.: 18703118